ANO1 protein as a potential biomarker for esophageal cancer prognosis and precancerous lesion development prediction

• Main Authors: Shang, L, Hao, J.-J, Zhao, X.-K, He, J.-Z, Shi, Z.-Z, Liu, H.-J, Wu, L.-F, Jiang, Y.-Y, Shi, F, Yang, H, Zhang, Y, Liu, Y.-Z, Zhang, T.-T, Xu, X, Cai, Y, Jia, X.-M, Li, M, Zhan, Q.-M, Li, E.-M, Wang, L.-D, Wei, W.-Q, Wang, M.-R
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: 2020
• Subjects: anoctamin 1; membrane protein; unclassified drug; ANO1 protein, human; tumor marker; tumor protein; adult; Article; cancer growth; cancer prognosis; cancer staging; cancer survival; cohort analysis; controlled study; esophagus biopsy; esophagus cancer; female; human; human tissue; immunohistochemistry; lymph node metastasis; major clinical study; male; middle aged; overall survival; precancer; predictive value; protein analysis; protein expression; protein function; survival prediction; biosynthesis; disease exacerbation; esophagus; esophagus tumor; Kaplan Meier method; metabolism; pathology; prognosis; squamous cell carcinoma; Anoctamin-1; Biomarkers, Tumor; Carcinoma, Squamous Cell; Disease Progression; Esophageal Neoplasms; Esophagus; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Proteins; Precancerous Conditions; Prognosis
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/179931
• Institution: National University of Singapore

10.18632/oncotarget.8223